EP0537232A4 - Recombinant pigeon pox virus vaccine - Google Patents
Recombinant pigeon pox virus vaccineInfo
- Publication number
- EP0537232A4 EP0537232A4 EP19910912297 EP91912297A EP0537232A4 EP 0537232 A4 EP0537232 A4 EP 0537232A4 EP 19910912297 EP19910912297 EP 19910912297 EP 91912297 A EP91912297 A EP 91912297A EP 0537232 A4 EP0537232 A4 EP 0537232A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- virus vaccine
- pox virus
- pigeon pox
- recombinant
- recombinant pigeon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000700667 Pigeonpox virus Species 0.000 title 1
- 229940024231 poxvirus vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54747090A | 1990-07-02 | 1990-07-02 | |
US547470 | 1990-07-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0537232A1 EP0537232A1 (en) | 1993-04-21 |
EP0537232A4 true EP0537232A4 (en) | 1993-06-30 |
Family
ID=24184753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19910912297 Withdrawn EP0537232A4 (en) | 1990-07-02 | 1991-07-01 | Recombinant pigeon pox virus vaccine |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0537232A4 (en) |
JP (1) | JPH05508540A (en) |
KR (1) | KR930701588A (en) |
AU (1) | AU8213391A (en) |
CA (1) | CA2084064A1 (en) |
WO (1) | WO1992000372A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025666A1 (en) * | 1992-06-16 | 1993-12-23 | Commonwealth Scientific And Industrial Research Organisation | Recombinant entomopoxvirus |
JPH08116976A (en) * | 1994-10-20 | 1996-05-14 | Chemo Sero Therapeut Res Inst | Nucleic acid preparation for immunization and immunizing method using the acid |
US6241991B1 (en) | 1998-03-05 | 2001-06-05 | Akzo Nobel N.V. | Aviadenovirus |
CN107630036A (en) * | 2017-10-16 | 2018-01-26 | 佛山科学技术学院 | A kind of Muscovy duck parvovirus VP1 genetic recombination pigeon avipoxvirus transfer vector |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0308220A1 (en) * | 1987-09-16 | 1989-03-22 | Nippon Zeon Co., Ltd. | Recombinant avipoxvirus |
EP0404576A2 (en) * | 1989-06-22 | 1990-12-27 | Nippon Zeon Co., Ltd. | Recombinant avipoxvirus |
EP0419666A1 (en) * | 1988-12-29 | 1991-04-03 | Nippon Zeon Co., Ltd. | Promoter, plasmid containing the same, and recombinant avipoxvirus |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429965A (en) * | 1966-08-01 | 1969-02-25 | Sterling Drug Inc | Avian pox virus vaccine and process of preparing same |
WO1988002022A1 (en) * | 1986-09-22 | 1988-03-24 | Commonwealth Scientific And Industrial Research Or | Recombinant poxviruses |
-
1991
- 1991-07-01 WO PCT/US1991/004675 patent/WO1992000372A1/en not_active Application Discontinuation
- 1991-07-01 KR KR1019920703430A patent/KR930701588A/en not_active Application Discontinuation
- 1991-07-01 AU AU82133/91A patent/AU8213391A/en not_active Abandoned
- 1991-07-01 CA CA002084064A patent/CA2084064A1/en not_active Abandoned
- 1991-07-01 EP EP19910912297 patent/EP0537232A4/en not_active Withdrawn
- 1991-07-01 JP JP91511819A patent/JPH05508540A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0308220A1 (en) * | 1987-09-16 | 1989-03-22 | Nippon Zeon Co., Ltd. | Recombinant avipoxvirus |
EP0419666A1 (en) * | 1988-12-29 | 1991-04-03 | Nippon Zeon Co., Ltd. | Promoter, plasmid containing the same, and recombinant avipoxvirus |
EP0404576A2 (en) * | 1989-06-22 | 1990-12-27 | Nippon Zeon Co., Ltd. | Recombinant avipoxvirus |
Non-Patent Citations (2)
Title |
---|
ARCHIVES OF VIROLOGY vol. 118, no. 1-2, 1991, WIEN, AUSTRIA pages 43 - 56 LETELLIER, C. ET AL. 'Construction of a pigeonpox virus recombinant: expresiion of the Newcastle disease virus (NDV9 fusion glycoprotein and protection of chickens against NDV challenge' * |
See also references of WO9200372A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1992000372A1 (en) | 1992-01-09 |
AU8213391A (en) | 1992-01-23 |
JPH05508540A (en) | 1993-12-02 |
KR930701588A (en) | 1993-06-12 |
CA2084064A1 (en) | 1992-01-03 |
EP0537232A1 (en) | 1993-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2246784B (en) | Herpes virus recombinant poxvirus vaccine | |
GB9303023D0 (en) | Flavivirus recombinant poxvirus vaccine | |
GB2245272B (en) | Recombinant virus selection system | |
AU2371692A (en) | Recombinant hepatitis a virus vaccine | |
EP0717636A4 (en) | Malaria recombinant poxvirus vaccine | |
DE69016956T2 (en) | Recombinant turkey herpes virus and derived live vaccine vector. | |
HU912526D0 (en) | Recombinant marek-type disease virus | |
FR2620459B1 (en) | RECOMBINANT VACCINE VIRUS | |
HUP9601466A2 (en) | Adjuvants for viral vaccines | |
ZA924150B (en) | Vaccine for human immunodeficiency virus | |
GB2264949B (en) | Measles virus recombinant poxvirus vaccine | |
HUP9601462A2 (en) | Adjuvants for viral vaccines | |
AU1257092A (en) | Interferon sensitive recombinant poxvirus vaccine | |
HU9300010D0 (en) | Glycoprotein vaccine named ehv-4 | |
AU5679394A (en) | Hepatitis b virus vaccines | |
EP0537232A4 (en) | Recombinant pigeon pox virus vaccine | |
EP0575544A4 (en) | Malaria recombinant poxvirus vaccine | |
EP0598759A4 (en) | Recombinant infectious bovine rhinotracheitis virus. | |
AU2347692A (en) | Recombinant viral vaccine | |
ZA908189B (en) | Infectious bronchitis virus vaccine | |
HU9203976D0 (en) | Vaccine based on modified herpes virus | |
AU2775692A (en) | Recombinant influenza virus vaccine compositions | |
ZA919198B (en) | Measles virus recombinant poxvirus vaccine | |
AU6051396A (en) | Measles virus recombinant poxvirus vaccine | |
GB9109763D0 (en) | Herpes virus vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19921210 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
RHK1 | Main classification (correction) |
Ipc: C12N 15/86 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19930511 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19950201 |